Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities:
Net loss	$ (8,051)	$ (7,586)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation of property and equipment	65	71
Interest income and unrealized gains from marketable securities, net	(2)	(105)
Share-based compensation	1,067	1,097
Changes in assets and liabilities:
Prepaid expenses and other assets	(274)	549
Other payables and accrued liabilities	(176)	(738)
Insurance recovery related to legal settlement and legal expenses received in cash	1,335
Legal settlement paid in cash	(1,100)
Net cash flows used in operating activities	(7,136)	(6,712)
Investing activities:
Purchases of property and equipment	(18)	(38)
Sale of property and equipment		2
Purchases of marketable securities	(5,120)	(8,379)
Proceeds from sales of marketable securities	2,680	2,039
Proceeds from maturities of marketable securities	2,500	5,389
Proceeds from short term deposit		3
Net cash flows provided by (used in) investing activities	42	(984)
Financing activities:
Issuance of common stock and warrants, net of issuance costs	5,104	6,558
Net cash flows provided by financing activities	5,104	6,558
Decrease in cash, cash equivalents and restricted cash	(1,990)	(1,138)
Cash, cash equivalents and restricted cash at beginning of period	2,517	2,519
Cash, cash equivalents and restricted cash at end of period	527	1,381
Supplemental disclosure of cash flow information:
Cash received from interest	168	100
Supplemental disclosure of non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease liabilities	37	20
Legal settlement settled through issuance of common stock	1,111
Accrued executive bonus settled through grant of stock-option awards	$ 76